Telix Pharmaceuticals Limited (Premium)



Ticker code: TLX

TLX Red Flags & Risk Indicators
⚠️ RED FLAGS: 6 identified

  • Low Operating Margin
  • Highly Shorted
  • Increasing Shorts
  • Falling Earnings
  • High Price to Book vs ROE
  • Falling EBITDA Margins

Income Statement
Revenue 2024 Per Share Revenue 2025e Per Share Revenue 2026e Per Share Revenue 24 to 25e [%] Revenue 25e to 26e [%] EBITDA 2024 Per Share EBITDA 2025e Per Share EBITDA 2026e Per Share EBITDA 24 to 25e [%] EBITDA 25e to 26e [%]
2.34004 3.65545 4.27444 56.2 16.9 0.29662 0.19301 0.3611 -34.9 87.1
TLX Revenue Per Share (2012–2027)
✅✅
Telix Pharmaceuticals Limited (TLX) Revenue Chart 2012–2027
TLX Earnings before Interest, Tax, Depreciation and Amortisation (EBITDA) Per Share (2012–2027)
Telix Pharmaceuticals Limited (TLX) EBITDA Chart 2012–2027
TLX Normalised Earnings Per Share (EPS) (2012–2027)
Telix Pharmaceuticals Limited (TLX) Normalised EPS Chart (2012–2027)

Valuation
Price To Sales Price To Book PER 2023 PER 2024 13Y Median PER Low PER 2025e 13Y Median PER High PER 2026e Last Updated
8.3 13.2 137.7 91.8 69.7 826.0 123.1 91.8 11/10/25
TLX Yearly Price Earnings Ratio (PER) Highs and Lows
Telix Pharmaceuticals Limited (TLX) PER Highs and Lows (2012–2027)
TLX Weekly Price Chart with Average True Range (ATR) Trailing Stop (10-Year View)
Telix Pharmaceuticals Limited (TLX) 10-Year Weekly ATR Trailing Stop Price Chart


Leave a Reply

Your email address will not be published. Required fields are marked *